Tesamorelin (5 mg Vial)
This reference covers Tesamorelin (5 mg Vial) in vial format: reconstitution steps, the concentration each volume produces, syringe-unit conversions and storage conditions for the lyophilized and reconstituted material.
CAT No:
CAS No:
Synonyms/Alias:Tesamorelin
M.F/Formula:
M.W/Mr.:
Purity:Specification by inquiry
- Sequence, purity and scale confirmation
- CoA and technical documentation requests
- API, research and cosmetic peptide options
- Distributor and institution quotation support
This reference covers Tesamorelin (5 mg Vial) in vial format: reconstitution steps, the concentration each volume produces, syringe-unit conversions and storage conditions for the lyophilized and reconstituted material.
Quickstart
Reconstitute: Add 2.5 mL bacteriostatic water per 5 mg vial → 2.0 mg/mL concentration.
Standard daily dose: 2 mg (2000 mcg) once daily subcutaneously (FDA-approved protocol).
Easy measuring: At 2.0 mg/mL, 1 unit = 0.01 mL = 20 mcg on a U-100 insulin syringe.
Storage: Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F); reconstituted: refrigerate and use within 7 days with bacteriostatic water.
Notes
Practical considerations for consistency and safety. Use new sterile insulin syringes for each injection; dispose in a sharps container [10]. Rotate injection sites (abdomen at least 2 inches from navel, thighs, upper arms) to reduce local irritation [6] [10]. Inject slowly; wait a few seconds before withdrawing the needle. Monitor IGF-1 levels periodically due to potent GH stimulation; observe blood glucose in diabetic patients [9]. Document daily dose and site rotation to maintain consistency.
Single peptide protocol reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Reconstitution and handling reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Research-use documentation inquiry : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Peptide Vials (Tesamorelin, 5 mg each): 8 weeks ≈ 23 vials (112 mg total)
12 weeks ≈ 34 vials (168 mg total)
16 weeks ≈ 45 vials (224 mg total)
Insulin Syringes (U-100, 1 mL capacity): Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use 2.5 mL per vial for reconstitution. 8 weeks (23 vials): 57.5 mL → 6 × 10 mL bottles
12 weeks (34 vials): 85 mL → 9 × 10 mL bottles
16 weeks (45 vials): 112.5 mL → 12 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100-count boxes
12 weeks: 168 swabs → recommend 2 × 100-count boxes
16 weeks: 224 swabs → recommend 3 × 100-count boxes
Send product, purity, quantity, destination and documentation requirements. Our team will follow up through online consultation or email.
WhatsApp: +852 52102460 +1 4422847013
Address: Huangpu District, Guangzhou, China